| abstract |
Heteroaryloxyheterocyclyl compounds, and compositions containing them, and processes for preparing such compounds are described. Methods for treating disorders or diseases treatable by PDE10 inhibition, such as obesity, non-insulin dependent diabetes, schizophrenia, Huntington's disease, bipolar disorder, obsessive-compulsive disorder, and the like are also provided herein. |